Clinical trial

A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared…

NCT00210561 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Terminated

Key facts

NCT number NCT00210561
Title A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back Pain
Official title A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) for the Treatment of Acute Low Back Pain
Lead sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry
Collaborators PriCara, Unit of Ortho-McNeil, Inc. Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Back Pain, Low Back Pain
Intervention type Drug
Interventions tramadol hydrochloride, acetaminophen
Enrollment 22
Start date Mar 1, 2005
Completion Apr 1, 2005
First posted Sep 21, 2005
Last update posted Jun 10, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies